LINC01087 and glioma: The contribution of LINC01087 to the pathogenesis of cancer, as well as its pivotal role as a biomarker, has been described only in a few oncological indications (i.e., BC, glioma, esophageal squamous cell carcinoma, and thyroid cancer) [32,36,37,38,39].